Reglagene
PrivateLast Round
Series A
Extension
Dec 19, 2023
Est. Valuation
$25.4M
Total Funding Raised
$7.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Reglagene is a therapeutics company that develops brain-penetrant small-molecule medicines for the treatment of brain cancers and other neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reglagene Comparables
Compare Reglagene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 84% | |
| Rgenta Therapeutics | 80% | |
| Gertrude Biomedical | 79% |
Reglagene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 19, 2023 | ||||
| Convertible Debt | Jun 1, 2021 | ||||
| Series A | Feb 1, 2021 | ||||
| Grant | Mar 9, 2020 | ||||
| Grant | Dec 19, 2019 | ||||
Grant | Sep 1, 2018 |
Reglagene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Tech Coast Angels | Series A Extension |
| Viva BioInnovator | Series A Extension |
| CANCER FUND | Series A, Series A Extension |
| Arizona Commerce Authority | Grant |
| TCA Venture Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 808% MoM, from 122 to 1.1K.
- Apr 20, 2026
Monthly visitors grew 37% MoM.
Reglagene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reglagene's valuation, stock price, and market status.
Is Reglagene a public or private company?
Reglagene is a private company.
What is the current stock price of Reglagene?
Reglagene is a private company, so its shares have no public market price. Caplight tracks Reglagene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reglagene worth (valuation)?
Reglagene's valuation is estimated at $25.4M based on funding round data.
Can I buy Reglagene stock?
Reglagene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reglagene's last funding round?
Reglagene's most recent funding round was Series A Extension on December 19, 2023.
Who are the main investors in Reglagene?
Key investors in Reglagene include CANCER FUND, Desert Angels.
Will Reglagene IPO soon?
No public IPO plans have been announced for Reglagene.
How can I track Reglagene secondary market activity?
Caplight tracks bids, offers, and trades in Reglagene's shares on secondary markets.